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Abstract
Molecular detection of gastrointestinal protozoa is more sensitive and more speciﬁc than microscopy but, to date, has not routinely
replaced time-consuming microscopic analysis. Two internally controlled real-time PCR assays for the combined detection of Entamoeba
histolytica, Giardia lamblia, Cryptosporidium spp. and Dientamoeba fragilis in single faecal samples were compared with Triple Faeces Test
(TFT) microscopy results from 397 patient samples. Additionally, an algorithm for complete parasitological diagnosis was created. Real-
time PCR revealed 152 (38.3%) positive cases, 18 of which were double infections: one (0.3%) sample was positive for E. histolytica, 44
(11.1%) samples were positive for G. lamblia, 122 (30.7%) samples were positive for D. fragilis, and three (0.8%) samples were positive
for Cryptosporidium. TFT microscopy yielded 96 (24.2%) positive cases, including ﬁve double infections: one sample was positive for
E. histolytica/Entamoeba dispar, 29 (7.3%) samples were positive for G. lamblia, 69 (17.4%) samples were positive for D. fragilis, and two
(0.5%) samples were positive for Cryptosporidium hominis/Cryptosporidium parvum. Retrospective analysis of the clinical patient information
of 2887 TFT sets showed that eosinophilia, elevated IgE levels, adoption and travelling to (sub)tropical areas are predisposing factors
for infection with non-protozoal gastrointestinal parasites. The proposed diagnostic algorithm includes application of real-time PCR to
all samples, with the addition of microscopy on an unpreserved faecal sample in cases of a predisposing factor, or a repeat request for
parasitological examination. Application of real-time PCR improved the diagnostic yield by 18%. A single stool sample is sufﬁcient for
complete parasitological diagnosis when an algorithm based on clinical information is applied.
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Introduction
In temperate, north-west European climates, a substantial
percentage of diarrhoeal complaints are caused by protozoan
pathogens, such as Entamoeba histolytica, Giardia lamblia, and
Cryptosporidium parvum/Cryptosporidium hominis. Although the
pathogenicity of Dientamoeba fragilis is still controversial, this
organism has recently gained attention as a possible cause
of gastrointestinal complaints and is therefore of relevance
for differential diagnostic purposes [1]. These parasites are
known to show day-to-day variation in faecal shedding of
trophozoites and cysts. Moreover, the detection of D. fragilis
necessitates preservation of the faecal specimen in preserva-
tives such as sodium acetate–acetic acid–formalin (SAF).
Therefore, the Triple Faeces Test (TFT) has been introduced,
enabling a higher diagnostic yield [2]. However, the proce-
dure requires considerable effort, both from the patient, in
collecting three faecal samples, and from the microbiological
laboratory, which has to examine all three samples using
microscopy. In addition, detection of C. parvum/C. hominis
requires additional staining to visualize the oocysts. Cysts
and trophozoites of E. histolytica are morphologically indistin-
guishable from those of the non-pathogenic Entamoeba dispar
and Entamoeba moshkovskii [3]. After microscopy, culture
methodology or, preferably, molecular identiﬁcation is still
required for differentiation of these three species [3].
PCR-based methods have proved to be both speciﬁc and
sensitive for the detection of protozoan infections [4–8], and
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allow high-throughput screening. Molecular diagnostics could
therefore represent an attractive alternative to TFT, remov-
ing the need for cumbersome faecal sampling by the patient,
as well as replacing time-consuming microscopy in the labo-
ratory. It also eliminates the need for SAF, one component
of which, formalin, contains the toxic carcinogen formalde-
hyde (5% or 10%).
In this study, TFT microscopy was compared with real-
time PCR for the detection of E. histolytica, G. lamblia, C. par-
vum/C. hominis, and D. fragilis, in individual unpreserved stool
samples. To enable high efﬁciency and an increased diagnos-
tic yield of gastrointestinal parasites, a diagnostic algorithm
was developed using a single faecal sample per patient.
Materials and Methods
An extended version of this section is included as Supporting
Information.
Faecal samples
Samples from 406 patients with gastrointestinal complaints
were collected between January 2007 and April 2007,
according to the TFT protocol, on three consecutive days
[2]. TFT sets consisted of two SAF-ﬁxed samples (TFT1 on
day 1 and TFT3 on day 3) and one unpreserved faecal sam-
ple (TFT2 on day 2). The complete set was sent by regular
mail to the Laboratory of Medical Microbiology and Infec-
tious Diseases of the Isala Clinics in Zwolle (The Nether-
lands). All samples were stored at 4C upon arrival until all
diagnostic tests had been performed.
Inclusion criteria were as follows: speciﬁc request for par-
asitological diagnosis because of gastrointestinal complaints,
adoption or, in the case of diagnostic requests without speci-
ﬁcation, persistent diarrhoea for more than 7 days.
Microscopy
Microscopic examination of the TFT sets was performed as
described previously [2]. Direct wet mounts of both SAF-
preserved samples (TFT1 and TFT3) were examined to
detect parasites. Positive or suspected direct smears were
further examined by Chlorazol Black permanent staining.
Microscopy for the presence of helminth ova and cysts was
performed using a Ridley concentrate of the unpreserved
TFT2 sample. Modiﬁed acid-fast staining for detection of
C. parvum/C. hominis on the formol–ether concentrate was
performed on speciﬁc request, on ﬂuidic stool samples, and
for samples from subjects under 16 years of age.
When indicators of helminth infection (e.g. eosinophilia)
were present, or a speciﬁc request was made to test for
helminth ova, the patients were requested to provide three
unpreserved samples, which were concentrated separately
and examined microscopically.
DNA extraction and real-time PCR
For real-time PCR, only unpreserved faeces samples (TFT2)
were examined. Approximately 200 mg of unpreserved fae-
ces was used for pretreatment (lysis and storage at )20C)
and DNA extraction. Prior to automatic DNA extraction,
phocid herpes virus (PhHV) (laboratory strain, provided by
the Erasmus MC Rotterdam, The Netherlands) was added as
an internal control. DNA was stored at )20C.
Real-time PCR: paraPCR
Detection of the four protozoa was performed in two reac-
tions per DNA sample. E. histolytica, G. lamblia and C. hominis/
C. parvum multiplex real-time PCR, including PhHV-1, was per-
formed as described previously [4], with some modiﬁcations to
the C. hominis/C. parvum oligonucleotides. D. fragilis DNA ampli-
ﬁcation was performed in a separate assay, also including
PhHV-1 [6]. Primer and probe sequences and their optimized
concentrations are listed in Table 1. The combination of multi-
plex and duplex reactions is hereafter referred to as ‘paraPCR’.
Analytical performance and analysis of real-time PCR
The analytical sensitivity and speciﬁcity of the PCRs used
have been validated by the Leiden University Medical Centre
(The Netherlands) [4,6,9], and conﬁrmed after the adjust-
ments to the protocol. Standardized adjustments to the anal-
ysis parameters in the Applied Biosystems 7500 software
were applied. Inhibition of the PCR reactions was measured
by the cycle threshold (Ct)-value of the PhHV ampliﬁcation.
Negative extraction and positive DNA controls for each
pathogen were included in all PCR runs.
Statistical analysis
The average Ct-values of PCR were compared between
microscopy groups by the Mann–Whitney test, using
SPSS 15.0, at a signiﬁcance level of p <0.05 (two-tailed).
Results
A total of 406 TFT sets were collected for parasitological
examination. Of these, nine were excluded because of
incomplete TFT sets or otherwise incomplete data, leaving
397 TFT sets for comparison.
Table 2 summarizes the comparison between the results
of microscopy of the complete TFT set and the results of
the paraPCR performed on the unpreserved (TFT2) faeces
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sample. In total, 158 (40%) of 397 sets revealed one or two
protozoa. G. lamblia was detected in 45 (11.3%) TFT sets
and D. fragilis in 127 (32.0%) TFT sets. Mixed infections with
G. lamblia and D. fragilis were detected in 18 patients by
paraPCR; ﬁve of these were also detected with microscopy.
In one case, E. histolytica/E. dispar was detected by micros-
copy, and E. histolytica-speciﬁc DNA was detected by
real-time PCR. The E. histolytica-positive and the C. parvum/
C. hominis-positive TFT sets did not reveal other pathogens.
Furthermore, microscopy revealed hookworm eggs in one
sample, and the non-pathogenic protozoa Blastocystis hominis,
Endolimax nana and Entamoeba coli were detected in 111, ten
and eight cases, respectively.
In 78 TFT sets, discrepancies were found between micros-
copy and paraPCR results. SAF-preserved faeces samples
were available for microscopic re-examination in 60 of 73
paraPCR-positive/microscopy-negative TFT sets. G. lamblia
could be conﬁrmed in eight of ten TFT sets and D. fragilis
could be conﬁrmed in 30 of 50 TFT sets after careful
re-examination of several additional slides. Of ﬁve TFT sets
initially found to be positive for D. fragilis by microscopy but
negative by paraPCR, on re-examination by microscopy,
three sets were found to be positive, whereas D. fragilis
could not be conﬁrmed in either TFT1 or TFT3 SAF-pre-
served samples of the two remaining sets. The paraPCR was
also repeated for these ﬁve sets, and yielded one positive
sample for D. fragilis. Hence, two microscopy-positive/para-
PCR-negative samples remained discrepant.
Ct-values were signiﬁcantly higher for DNA samples from
TFT sets in which D. fragilis was not found by microscopy
(n = 58, median Ct 31.0, range 21.3–40.1) than for those
from sets in which D. fragilis was detected by microscopy
(n = 64, median Ct 25.8, range 18.4–37.3) (Mann–Whitney
test; p <0.0001). A statistical difference was also found
between the Ct-values of the sets in which D. fragilis troph-
ozoites were detected in both SAF samples (n = 36, median
Ct 23.5, range 18.4–35.0) and those of the sets in which
trophozoites were detected in only one of the two SAF sam-
ples (n = 28, median Ct 26.3, range 19.4–37.3) (Mann–Whit-
ney test; p 0.037).
The Ct-values of the G. lamblia-speciﬁc PCR showed a
similar distribution to the Ct-values of the D. fragilis PCR:
Ct-values were higher in DNA samples from TFT sets in
which G. lamblia was not found by microscopy (n = 16, med-
ian Ct 35.4, range 29.6–42.8) than in those from sets in
which G. lamblia was detected by microscopy (n = 28, med-
ian Ct 26.0, range 19.1–37.8) (Mann–Whitney test;
p <0.0001).
Inhibition was observed in the paraPCR in 20 stool
samples. Twelve samples were inhibited completely (no
PhHV signal or a Ct value >40), and eight samples were par-
tially inhibited (only one of two PhHV signals per sample
yielded a Ct value >40). A small pilot study was performed
TABLE 2. Results of microscopy of complete Triple Faeces
Test sets and paraPCR for individual unpreserved stool










Entamoeba histolytica 1 – – 396
Giardia lamblia 28 1a 16 352
Cryptosporidium
parvum/hominis
2 – 1 394
Dientamoeba fragilis 64 5 58 270
Microscopic re-examinations of discrepant samples are not included. Results of
repeated paraPCR of initially inhibited samples are included. The protozoa in
mixed infections are presented as separate detections.
aOne PCR inhibited sample was positive for G. lamblia by microscopy and is
included in the Microscopy+/PCR) results for G. lamblia.
TABLE 1. Primers and probes used in real-time PCR assays
Target organism Oligonucleotide Sequence (5¢–3¢) and labels
Amount (pmol) added to
30 lL of reaction mix Reference
Giardia lamblia Sense primer GAC GGC TCA GGA CAA CGG TT 3.7 [4]
Antisense primer TTG CCA GCG GTG TCC G 3.7
Probe FAM-CCC GCG GCG GTC CCT GCT AG-BHQ 3.0
Cryptosporidium parvum/
Cryptosporidium hominis
Sense primer CTT TTT ACC AAT CAC AGA ATC ATC AGA 15.0 This
publication
Antisense primer TGT GTT TGC CAA TGC ATA TGA A 15.0
Probe NED-TCG ACT GGT ATC CCT ATA A-MGB 3.0
Entamoeba histolytica Sense primer ATT GTC GTG GCA TCC TAA CTC A 3.7 [4]
Antisense primer GCG GAC GGC TCA TTA TAA CA 3.7
Probe VIC-TCA TTG AAT GAA TTG GCC ATT T-MGB 1.5
Dientamoeba fragilis Sense primer CAA CGG ATG TCT TGG CTC TTT A 4.5 [6]
Antisense primer TGC ATT CAA AGA TCG AAC TTA TCA C 4.5
Probe FAM-CAA TTC TAG CCG CTT AT-MGB-BHQ 3.0
PhHV Sense primer GGG CGA ATC ACA GAT TGA ATC 4.5 [9]
Antisense primer GCG GTT CCA AAC GTA CCA A 4.5
probe Cy5-TTT TTA TGT GTC CGC CAC CAT CTG GAT C-BHQ 3.0
PhHV, phocid herpes virus; BHQ, Black Hole Quencher; MGB, Minor Groove Binder. Fluorophores: Cy5, FAM, NED, and VIC.
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to investigate the inﬂuence that different starting points in
the protocol had on inhibition. Only a freeze–thaw step on
the inhibited DNA extract, a new DNA extraction from pre-
treated faeces and a new DNA extraction from the original
stool sample were compared (n = 20). The results of this
pilot study showed that inhibiting factors were already pres-
ent in the pretreated sample, and only repeating the extrac-
tion protocol from the original stool sample was successful
in diminishing inhibition. Eighteen of the 20 samples showed
no inhibition, whereas two samples showed inhibition again
when DNA was re-extracted and real-time PCR was
repeated (one sample was positive for G. lamblia by micros-
copy, and one sample was negative by microscopy).
Analysis of the microscopy results of TFT sets (n = 2887)
over a 10-month period (May 2006 to March 2007) revealed
nine positive results for non-protozoan parasitic infections:
Enterobius vermicularis (n = 2), Ascaris lumbricoides, Trichuris
trichiura, Strongyloides stercoralis, Taenia sp. (ova), Taenia saginat-
a (proglottid), Hymenolepis nana, and a hookworm. Four
diagnoses resulted from speciﬁc requests for a single patho-
gen: S. stercoralis (n = 1), Taenia sp. (n = 2), and Enterobius ver-
micularis (n = 1). In three cases, a link with speciﬁc risk factors
could be made: travelling to risk areas or showing eosinophilia.
One case was not related to speciﬁc risk factors (H. nana) and
one case appeared to be a coincidental diagnosis without any
relation to the complaints (Enterobius vermicularis).
Discussion
The comparison of microscopy with paraPCR for the detection
of gastrointestinal protozoa yielded 152 (38.3%) positive faecal
samples by paraPCR vs. 96 (24.2%) positive TFT sets detected
by microscopy, for one or more pathogenic protozoa. When
the faecal samples that were either positive by microscopy,
positive by paraPCR or positive by both were deﬁned as ‘true
positives’, the sensitivity of paraPCR was clearly superior to
that of microscopy (96% vs. 54% for D. fragilis and 98% vs. 64%
for G. lamblia, respectively). Moreover, the Ct-values of
D. fragilis-speciﬁc and G. lamblia-speciﬁc signals, reﬂecting the
amount of parasite-derived DNA in the samples, correlated sig-
niﬁcantly with the microscopy results. This is fully in accordance
with earlier comparisons of microscopy and the more sensitive
molecular approaches [8–10]. In our study, one patient was
found to be positive for E. histolytica, which causes a potentially
life-threatening infection. Although E. histolytica/E. dispar was
detected by microscopy, E. histolytica had to be conﬁrmed by
molecular examination. An interesting observation in the pres-
ent study was the low prevalence of C. parvum/C. hominis when
compared with previous ﬁndings in The Netherlands [10]. This
may be explained by the different time of year in which the
samples were collected, as it is known that the incidence of
C. parvum/C. hominis infections is highly seasonal.
The number of samples in which PCR was inhibited
(n = 20; 5%) might be considered to be high. As earlier stud-
ies have shown [4,11], further optimization of the DNA
extraction protocol should be possible to increase the yield
of uninhibited extracts to nearly 100% of samples. However,
by repeating the pretreatment and DNA extraction proto-
cols for the inhibited samples, a simple practice that is suit-
able for high throughput, we managed to decrease the
number of inhibited samples to a mere 0.5%. The superior
sensitivity of the paraPCR allows a diagnosis using an individ-
ual faecal sample without the need for preservative. Micros-
copy requires SAF preservative for the detection of
D. fragilis, whereas PCR detection of D. fragilis DNA is as
sensitive with unpreserved faeces, after several weeks of
storage, as with a fresh sample [6]. Therefore, with the appli-
cation of the more sensitive paraPCR, only a single stool
sample, without preservation ﬂuid, is sufﬁcient for the diag-
nosis of gastrointestinal protozoa.
Although studies have been published on the clinical rele-
vance of D. fragilis [12–17], the pathogenic properties of
D. fragilis have not yet been completely elucidated. The D. fra-
gilis prevalence found in the present study with microscopy
alone (17.4%) is higher than reported elsewhere, ranging
from <1% [15,18] to 16.8% [19]. Positive microscopy results
were conﬁrmed by PCR in 64 of 69 samples (92.7%). PCR
has shown a speciﬁcity approaching 100% [4,19]. Comparison
of our results with those of previous publications remains
difﬁcult, because of differences in almost every aspect, includ-
ing deﬁnitions of signs and symptoms, clinical protocols for
diagnosis, and laboratory methods.
To date, no genetic differences between D. fragilis isolates
from clinical cases and isolates from controls have been
described. A future case–control study would be necessary
to prove the clinical signiﬁcance of D. fragilis in this patient
population, together with a genotyping study to establish
type distribution in this geographical area.
Molecular methods will detect the speciﬁed target organ-
isms only. A disadvantage of the paraPCR approach, there-
fore, is that other organisms, for which microscopy is
essential for diagnosis, e.g. helminths, escape detection.
Microscopy will thus remain necessary for the diagnosis of
other pathogenic parasites that are not included in the PCR
assay used. Unfortunately, detection of these additional
pathogens cannot always be predicted from speciﬁc signs and
symptoms or other information conveyed by the clinician
requesting the microbiological investigation. Nevertheless,
microscopy is necessary to minimize the chance of missing
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other parasitic pathogens, even when the prevalence of non-
protozoal parasites is low, which may be the case in particu-
lar diagnostic settings or patient populations. For example, in
our laboratory, only nine helminth infections have been diag-
nosed in 2887 patients over a 10-month period. We have
therefore designed an algorithm that includes microscopy in
the parasitological examination for helminths or protozoa
such as Isospora belli or Cyclospora cayetanensis only when
necessary. Criteria for the use of microscopy to detect these
parasitic pathogens are: an explicit request for speciﬁc parasi-
tological investigation, eosinophilia, increased IgE level
(>120 U/mL), urticaria, a history of recent travel to the
(sub)tropics, adoption, an impaired immune system, or,
ﬁnally, persistent or recurrent complaints after a previous
analysis by paraPCR, within a period of 2 months. If micros-
copy for the detection of helminths had been performed
according to one or more of these criteria, seven of the nine
cases would have been correctly identiﬁed. The only two
cases missed through the lack of an initial diagnostic request,
the two remaining helminth cases, would have been detected
in the repeat sample.
In our laboratory, using microscopy, a single technician is
able to process TFT samples from 15 patients per day (8 h
of hands-on time), as opposed to processing a maximum of
about 90 patient samples by paraPCR in same time period.
Routine application of the proposed algorithm for parasito-
logical diagnostics in our laboratory has reduced the number
of microscopic examinations by about 90%. The remaining
10% of the examinations were triggered by one or more cri-
teria for the performance of microscopy. Because a single
sample is now sufﬁcient for adequate diagnosis, including
microscopy, a signiﬁcant reduction in the need for scarce
technician time has been accomplished per examination.
In conclusion, implementation of paraPCR for the diagno-
sis of parasitic gastrointestinal infections yields the beneﬁts of
less hands-on time, higher sensitivity, direct differentiation of
E. histolytica from other Entamoeba, and a shorter turnaround
time, and requires only one unpreserved stool sample.
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